PCI术后造影剂脑病1例及诊疗策略

A Case of Contrast-Induced Encephalopathy Induced by a Percutaneous Coronary Intervention and Its Diagnosis and Treatment Strategy

摘要: 目的：通过病例报道认识造影剂脑病的诊疗策略。方法：回顾分析1例经皮冠状动脉介入治疗术导致造影剂脑病的临床资料，分析其致病原因、临床表现、诊治策略和预后。结果：造影剂脑病是一种少见的由造影剂引起的神经功能紊乱的不良反应，确诊后应积极治疗，可防止脑功能不可逆的损害。结论：造影剂脑病的病因复杂，应首先排除威胁生命的病症，积极处理，预后良好。

Abstract: Objective: To understand the diagnosis and treatment strategy of contrast encephalopathy through case reports. Methods: The clinical data of a case of contrast encephalopathy caused by percutaneous coronary intervention were retrospectively analyzed. The causes, clinical manifestations, diagnosis and treatment strategies and prognosis were analyzed. Results: Contrast encephalopathy is an adverse reaction accompanied by a neurological disorder caused by a contrast agent. Active treatment should be done after diagnosis to prevent irreversible damage to brain function. Conclusion: The etiology of contrast-enhancing encephalopathy is complex. It should first be excluded from life-threatening conditions, and then actively treated, and the prognosis is good.